# Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)

> **NCT03566693** · NA · COMPLETED · sponsor: **DexCom, Inc.** · enrollment: 176 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** Dexcom G6 CGM System
- **DEVICE:** Blood glucose meter

## Key facts

- **NCT ID:** NCT03566693
- **Lead sponsor:** DexCom, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-30
- **Primary completion:** 2021-01-04
- **Final completion:** 2021-01-04
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2021-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03566693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03566693, "Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03566693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*